A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer

Published:2015-02 Issue:2 Volume:16 Page:225-232
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Zhang Jian,Wang Leiping,Wang Zhonghua,Hu Xichun,Wang Biyun,Cao Jun,Lv Fangfang,Zhen Chunlei,Zhang Sheng,Shao Zhimin

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/15384047.2014.986973

Reference39 articles.

1. Triple-Negative Breast Cancer: Risk Factors to Potential Targets

2. Triple negative tumours: a critical review

3. Pattern of metastatic spread in triple-negative breast cancer

4. Molecular portraits of human breast tumours

5. Triple-Negative Breast Cancer

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the Efficacy and Safety of Chemotherapy Plus Everolimus in HER2-Negative Metastatic Breast Cancer Harboring Altered PI3K/AKT/mTOR;Discovery Medicine;2024

2. Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review;Biomedicines;2023-06-20

3. Functionalized liposomes for targeted breast cancer drug delivery;Bioactive Materials;2023-06

4. Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial;BMC Cancer;2023-05-19

5. Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial;npj Breast Cancer;2022-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3